NCT00382044View on ClinicalTrials.gov

Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions
Kidney Failure, ChronicAnemia
Interventions
DRUG

Eprex; Neorecormon; Aranesp

Trial Locations (1)

6009

Sir Charles Gairdner Hospital, Perth

All Listed Sponsors
lead

Sir Charles Gairdner Hospital

OTHER

NCT00382044 - Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients | Biotech Hunter | Biotech Hunter